Key result
Tailored perioperative management and physiology-based risk stratification minimize complications in congenital heart disease.
Why the study?
Recent literature in 2022 relevant to anesthesiologists caring for children and adults with congenital heart disease was reviewed to address key themes in the field.
Synthesizes 2022 evidence for congenital heart disease anesthesia; leaves open prospective confirmation of enhanced recovery and neuromonitoring benefits.
This review focuses on the literature published during the calendar year 2022 that is of interest to anesthesiologists taking care of children and adults with congenital heart disease (CHD). Four major themes are discussed: enhanced recovery after surgery(ERAS); diversity, equity, and inclusion; the state of pediatric cardiac anesthesiology as a subspecialty in the United States; and neuromonitoring for pediatric cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Goodmanson et al. (2023) conducted a review in Congenital heart disease. Perioperative anesthesia management was evaluated. Perioperative anesthesia management for patients with congenital heart disease requires careful risk stratification and understanding of complex cardiac physiology to minimize complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: